Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 2 | 955 | 306 | 0.2058 | 0.2359 | 0.3204 | 0.2994 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 3 | 496 | 140 | 0.1129 | 0.2359 | 0.2823 | 0.2994 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 1 | 526 | 138 | 0.1230 | 0.1027 | 0.2624 | 0.2808 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 2 | 446 | 136 | 0.0983 | 0.1027 | 0.3049 | 0.2808 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 3 | 378 | 104 | 0.0869 | 0.1027 | 0.2751 | 0.2808 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 1 | 3528 | 190 | 0.9630 | 1.0000 | 0.0539 | 0.0545 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 3736 | 214 | 1.0161 | 1.0000 | 0.0573 | 0.0545 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 3 | 3734 | 195 | 1.0210 | 1.0000 | 0.0522 | 0.0545 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 1 | 4085 | 262 | 1.1029 | 1.3927 | 0.0641 | 0.0616 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 2 | 5640 | 348 | 1.5267 | 1.3927 | 0.0617 | 0.0616 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 3 | 5704 | 336 | 1.5486 | 1.3927 | 0.0589 | 0.0616 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 1 | 3148 | 195 | 0.8519 | 0.7323 | 0.0619 | 0.0602 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 2 | 2823 | 172 | 0.7648 | 0.7323 | 0.0609 | 0.0602 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 3 | 2134 | 123 | 0.5802 | 0.7323 | 0.0576 | 0.0602 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 2113 | 106 | 0.5790 | 0.4111 | 0.0502 | 0.0604 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 2 | 1525 | 91 | 0.4137 | 0.4111 | 0.0597 | 0.0604 |
MZ7-mel | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 3 | 898 | 64 | 0.2406 | 0.4111 | 0.0713 | 0.0604 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 2050 | 110 | 0.5597 | 0.6853 | 0.0537 | 0.0479 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 2653 | 123 | 0.7299 | 0.6853 | 0.0464 | 0.0479 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 2777 | 121 | 0.7662 | 0.6853 | 0.0436 | 0.0479 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 2852 | 143 | 0.7815 | 0.9528 | 0.0501 | 0.0436 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 2 | 3775 | 147 | 1.0466 | 0.9528 | 0.0389 | 0.0436 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 3 | 3726 | 155 | 1.0302 | 0.9528 | 0.0416 | 0.0436 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2768 | 138 | 0.7587 | 0.6073 | 0.0499 | 0.0523 |
MZ7-mel | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 2 | 2344 | 121 | 0.6413 | 0.6073 | 0.0516 | 0.0523 |